Within a day: two pharmaceutical companies have applied for a vaccine approval for Corona Israel today

Pfizer has announced that it has submitted a request for approval for the corona vaccine to the European Medicines Agency • The request comes a day after Moderna announced that it would submit an application to the FDA

Pfizer announced today (Tuesday) that it has submitted to the European Medicines Agency an application for approval for the corona vaccine it is developing.

The request comes a day after a modern company, which develops its own vaccine, announced that it would submit an application for approval to the US FDA.

In addition to submitting the application for emergency approval in the United States, the company will submit a parallel application for approval by the European Medicines Agency, which has already begun testing the trial data.

Photo: Pfizer

On Saturday, the British economic newspaper "Financial Times" reported that Britain is ready to approve the coronation vaccine of the American pharmaceutical company Pfizer as early as next week.

According to the report, delivery is expected to begin on the same day that the vaccines are approved.

The UK has ordered a total of 40 million vaccine doses, and hopes to vaccinate 5 million people by the end of the year by using 10 million vaccine doses.   

According to results published by Pfizer, the vaccine has shown 95% efficacy.

Last weekend the company submitted the application to approve the vaccine to the FDA, where it is hoped to approve the vaccine on December 10th.

Israel has a vaccination agreement with Pfizer, as well as with the British company Astraznica and the American Modern. 

As for modernity, the company claims that according to the results of advanced clinical trial stages, the vaccine effectiveness now stands at 94.1%, while at the same time no side effects or worrying health problems were observed among the experimenters.

The company added that it has reported 100 percent success in preventing difficult cases.

The company's medical director, the Israeli Dr. Tal Zacks, said in an interview: "We believe that the vaccine we developed is highly effective, and now we also have the information to prove it.

We expect to play a key role in reversing the epidemic. "